Literature DB >> 16920225

CRF receptors in the rodent and human cardiovascular systems: species differences.

Beatrice Waser1, Ruth Rehmann, Jean Rivier, Wylie Vale, Jean Claude Reubi.   

Abstract

CRF has powerful receptor-mediated cardiovascular actions. To evaluate the precise distribution of CRF receptors, in vitro CRF receptor autoradiography with (125)I-[Tyr(0), Glu(1), Nle(17)]-sauvagine or [(125)I]-antisauvagine-30 was performed in the rodent and human cardiovascular system. An extremely high density of CRF(2) receptors was detected with both tracers in vessels of rodent lung, intestine, pancreas, mesenterium, kidney, urinary bladder, testis, heart, brain, and in heart muscle. In humans, CRF(2) receptors were detected with (125)I- antisauvagine-30 at low levels in vessels of kidneys, intestine, urinary bladder, testis, heart and in heart muscle, while only heart vessels were detected with (125)I-[Tyr(0), Glu(1), Nle(17)]-sauvagine. This is the first extensive morphological study reporting the extremely wide distribution of CRF(2) receptors in the rodent cardiovascular system and a more limited expression in man, suggesting a species-selective CRF receptor expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920225     DOI: 10.1016/j.peptides.2006.07.005

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  CRF and urocortin 3 protect the heart from hypoxia/reoxygenation-induced apoptosis in zebrafish.

Authors:  Tegan A Williams; Jillian C Bergstrome; Juliana Scott; Nicholas J Bernier
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-05-24       Impact factor: 3.619

2.  Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.

Authors:  Marilyn H Perrin; Laura A Tan; Joan M Vaughan; Kathy A Lewis; Cynthia J Donaldson; Charleen Miller; Judit Erchegyi; Jean E Rivier; Paul E Sawchenko
Journal:  J Pharmacol Exp Ther       Date:  2015-03-03       Impact factor: 4.030

3.  cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.

Authors:  Li-Zhen Yang; Jens Kockskämper; Shelina Khan; Jorge Suarez; Stefanie Walther; Bernhard Doleschal; Gregor Unterer; Mounir Khafaga; Heinrich Mächler; Frank R Heinzel; Wolfgang H Dillmann; Burkert Pieske; Joachim Spiess
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

4.  RFamide-related peptide and messenger ribonucleic acid expression in mammalian testis: association with the spermatogenic cycle.

Authors:  Sheng Zhao; Edward Zhu; Christina Yang; George E Bentley; Kazuyoshi Tsutsui; Lance J Kriegsfeld
Journal:  Endocrinology       Date:  2010-01-05       Impact factor: 4.736

5.  Neuropeptides in the gonads: from evolution to pharmacology.

Authors:  Nicolette L McGuire; George E Bentley
Journal:  Front Pharmacol       Date:  2010-09-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.